Construction of a retroviral vector production system with the minimum possibility of a homologous recombination

Gene Therapy

Volumn 10, Issue 8, 2003, Pages 706-711

  Yu, Seung Shin ^a,b   Han, Eunyoung ^a   Hong, Youngtae ^b   Lee, Jun Tae ^b   Kim, Sujeong ^a   Kim, Sunyoung ^a,b  

^a ViroMed Co Ltd   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Homologous recombination; Packaging line; RCR; Retroviral vector

Indexed keywords

GAG PROTEIN; POL PROTEIN; RETROVIRUS VECTOR; VIRUS ENVELOPE PROTEIN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; GENE SEQUENCE; GENETIC CODE; HOMOLOGOUS RECOMBINATION; MURINE LEUKEMIA VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PLASMID; PRIORITY JOURNAL; SEQUENCE ANALYSIS; START CODON; STOP CODON; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION; VIRUS TITRATION;

BASE SEQUENCE; BIOREACTORS; BLOTTING, NORTHERN; CELL LINE; GENE THERAPY; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; MOLECULAR SEQUENCE DATA; RECOMBINATION, GENETIC; RETROVIRIDAE; VIRUS REPLICATION;

MURINAE; MURINE LEUKEMIA VIRUS; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0037728737     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301892     Document Type: Article

References (20)

1. Chong H, Starkey W, Vile RG. A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences. J Virol 1998; 72: 2663-2670.
2. Otto E et al. Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences. Hum Gene Ther 1994; 5: 567-575.
3. Garrett E et al. Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell line. Virology 2000; 266: 170-179.
4. Yu SS, Kim JM, Kim S. High efficiency retroviral vectors that contain no viral coding sequences. Gene Ther 2000; 7: 797-804.
5. Dranoff G et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 1993; 90: 3539-3543.
6. Finer MH et al. kat: a high-efficiency retroviral transduction system for primary human T lymphocytes. Blood 1994; 83: 43-50.
7. Byun J et al. A simple and rapid method for the determination of recombinant retrovirus titer by G418 selection. Gene Ther 1996; 3: 1018-1020.
8. Pear WS, Nolan GP, Scott ML, Baltimore D. Production of high titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 1993; 90: 8392-8396.
9. Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA 1988; 85: 6460-6464.
10. Markowitz D, Goff S, Bank A. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 1988; 62: 1120-1124.
11. Soneoka Y et al. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 1995; 23: 628-633.
12. Miller AD, Roseman GJ. Improved retroviral vectors for gene transfer and expression. Biotechniques 1989; 7: 980-990.
13. Cosset FL et al. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 1995; 69: 7430-7436.
14. Lee Y et al. Improved expression of vascular endothelial growth factor by naked DNA in mouse skeletal muscles: implication for gene therapy of ischemic diseases. Biochem Biophys Res Commun 2000; 272: 230-235.
15. Kim VN, Mitrophanous K, Kingsman SM, Kingsman AJ. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J Virol 1998; 72: 811-816.
16. Cornetta K et al. Amphotropic murine leukemia retrovirus is not an acute pathogen for primates. Hum Gene Ther 1990; 1: 15-30.
17. Donahue RE et al. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 1992; 176: 1125-1135.
18. Sheridan PL et al. Generation of retroviral packaging and producer cell lines for large- scale vector production and clinical application: improved safety and high titer. Mol Ther 2000; 2: 262-275.
19. Hildinger M, Abel KL, Ostertag W, Baum C. Design of 5′ untranslated sequences in retroviral vectors developed for medical use. J Virol 1999; 73: 4083-4089.
20. Shinnick TM, Lerner RA, Sutcliffe JG. Nucleotide sequence of Moloney murine leukaemia virus. Nature 1981; 293: 543-548.